Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

VALVULAR DISEASE

Incidence of new-onset AF after TAVI and AVR

Subjects

New-onset atrial fibrillation (AF) is a common complication affecting patients who undergo aortic valve replacement (AVR) and transcatheter aortic valve implantation (TAVI), according to a population-based, observational study. The analysis included 48,715 patients admitted to hospital to receive TAVI and 122,765 to receive AVR. New-onset AF was observed in 50.4% of TAVI hospitalizations and 50.1% of AVR hospitalizations. Patients with new-onset AF also had a greater prevalence of coronary artery disease, congestive heart failure and peripheral vascular disease than those without new-onset AF. Furthermore, new-onset AF was associated with prolonged hospitalization and higher in-hospital mortality.

References

Original article

  1. Kalra, R. et al. Evaluation of the incidence of new-onset atrial fibrillation after aortic valve replacement. JAMA Intern. Med. https://doi.org/10.1001/jamainternmed.2019.0205 (2019)

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Karina Huynh.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Huynh, K. Incidence of new-onset AF after TAVI and AVR. Nat Rev Cardiol 16, 454 (2019). https://doi.org/10.1038/s41569-019-0229-7

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing